Significance of Bioactive Substances in Metabolic Diseases

Significance of Bioactive Substances in Metabolic Diseases - Significance of Bioactive Substances in Metabolic Diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004192

Enrollment

3000

Registered

2010-09-11

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: subjects with metabolic diseases

Exclusion criteria

Exclusion criteria: 1. infectious dieases 2. non informed consent 3. unsuitable subjects decided by doctor

Design outcomes

Primary

Measure	Time frame
Concentrations of bioactive substances in blood and urine	—

Countries

Japan

Contacts

Public ContactNorikazu Maeda

Graduate School of Medicine, Osaka University Department of Metabolic Medicine

norikazu_maeda@endmet.med.osaka-u.ac.jp06-6879-3732

Outcome results